Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment and prevention of intravascular coagulation with antiserum to endotoxin.

× No keyword cloud information.

17 in total

1. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum.

Authors: J Hellman; P M Loiselle; M M Tehan; J E Allaire; L A Boyle; J T Kurnick; D M Andrews; K Sik Kim; H S Warren
Journal: Infect Immun Date: 2000-05 Impact factor: 3.441

2. Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.

Authors: Catherine H Valentine; Judith Hellman; Laura K Beasley-Topliffe; Aranya Bagchi; H Shaw Warren
Journal: Mol Med Date: 2006 Sep-Oct Impact factor: 6.354

Review 3. Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors: I G Mitov; D G Terziiski
Journal: Infection Date: 1991 Nov-Dec Impact factor: 3.553

Review 4. Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors: D L Dunn
Journal: World J Surg Date: 1987-04 Impact factor: 3.352

5. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria.

Authors: M Trautmann; H Hahn
Journal: Infection Date: 1985 May-Jun Impact factor: 3.553

6. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

Authors: M I Marks; E J Ziegler; H Douglas; L B Corbeil; A I Braude
Journal: J Clin Invest Date: 1982-04 Impact factor: 14.808

7. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.

Authors: J Fierer; F Finley
Journal: J Clin Invest Date: 1979-05 Impact factor: 14.808

8. Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.

Authors: B W Fenwick; J S Cullor; B I Osburn; H J Olander
Journal: Infect Immun Date: 1986-08 Impact factor: 3.441

9. Endotoxaemia and renal failure in cirrhosis and obstructive jaundice.

Authors: S P Wilkinson; H Moodie; J D Stamatakis; V V Kakkar; R Williams
Journal: Br Med J Date: 1976-12-11

10. Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis.

Authors: E T Rietschel; C Galanos
Journal: Infect Immun Date: 1977-01 Impact factor: 3.441